Atossa Genetics Stock Fundamentals
| ATOS Stock | USD 1.50 0.01 0.67% |
Atossa Genetics fundamentals help investors to digest information that contributes to Atossa Genetics' financial success or failures. It also enables traders to predict the movement of Atossa Stock. The fundamental analysis module provides a way to measure Atossa Genetics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Atossa Genetics stock.
At this time, Atossa Genetics' Selling And Marketing Expenses is comparatively stable compared to the past year. Other Operating Expenses is likely to gain to about 32.9 M in 2024, whereas Interest Expense is likely to drop 8,740 in 2024. Atossa | Select Account or Indicator |
Atossa Genetics Company Shares Owned By Insiders Analysis
Atossa Genetics' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Atossa Genetics Shares Owned By Insiders | 0.06 % |
Most of Atossa Genetics' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Atossa Genetics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 0.059% of Atossa Genetics are shares owned by insiders. This is 99.61% lower than that of the Health Care Equipment & Supplies sector and 99.58% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 99.42% higher than that of the company.
Atossa Genetics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Atossa Genetics's current stock value. Our valuation model uses many indicators to compare Atossa Genetics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Atossa Genetics competition to find correlations between indicators driving Atossa Genetics's intrinsic value. More Info.Atossa Genetics is rated second in return on equity category among related companies. It is rated second in return on asset category among related companies . At this time, Atossa Genetics' Return On Equity is comparatively stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Atossa Genetics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Atossa Genetics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Atossa Genetics' earnings, one of the primary drivers of an investment's value.Atossa Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Atossa Genetics' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Atossa Genetics could also be used in its relative valuation, which is a method of valuing Atossa Genetics by comparing valuation metrics of similar companies.Atossa Genetics is currently under evaluation in shares owned by insiders category among related companies.
Atossa Genetics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Atossa Genetics from analyzing Atossa Genetics' financial statements. These drivers represent accounts that assess Atossa Genetics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Atossa Genetics' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 4.2M | 13.3M | 10.7M | 111.0M | 99.9M | 104.8M | |
| Enterprise Value | (6.1M) | 809.6K | (28.8M) | 22.4M | 25.7M | 27.0M |
Atossa Fundamentals
| Return On Equity | -0.29 | ||||
| Return On Asset | -0.18 | ||||
| Current Valuation | 89.47 M | ||||
| Shares Outstanding | 125.3 M | ||||
| Shares Owned By Insiders | 0.06 % | ||||
| Shares Owned By Institutions | 19.20 % | ||||
| Number Of Shares Shorted | 10.56 M | ||||
| Price To Earning | (0.62) X | ||||
| Price To Book | 2.30 X | ||||
| EBITDA | (31.35 M) | ||||
| Net Income | (30.09 M) | ||||
| Cash And Equivalents | 125.54 M | ||||
| Cash Per Share | 0.99 X | ||||
| Total Debt | 1.22 K | ||||
| Current Ratio | 35.19 X | ||||
| Book Value Per Share | 0.73 X | ||||
| Cash Flow From Operations | (20.94 M) | ||||
| Short Ratio | 5.37 X | ||||
| Earnings Per Share | (0.24) X | ||||
| Target Price | 4.58 | ||||
| Number Of Employees | 12 | ||||
| Beta | 1.24 | ||||
| Market Capitalization | 186.7 M | ||||
| Total Asset | 96.25 M | ||||
| Retained Earnings | (186.29 M) | ||||
| Working Capital | 112.63 M | ||||
| Current Asset | 4.29 M | ||||
| Current Liabilities | 2.5 M | ||||
| Net Asset | 96.25 M |
About Atossa Genetics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Atossa Genetics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atossa Genetics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atossa Genetics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 1.2 M | 985.6 K | |
| Total Revenue | 0.00 | 0.00 | |
| Cost Of Revenue | 23 K | 21.9 K | |
| Stock Based Compensation To Revenue | 430.09 | 451.59 | |
| Sales General And Administrative To Revenue | 4.5 K | 4.8 K | |
| Research And Ddevelopement To Revenue | 1.2 K | 1.3 K | |
| Capex To Revenue | (66.93) | (63.58) | |
| Revenue Per Share | 0.01 | 0.01 | |
| Ebit Per Revenue | -8.3 K | -7.9 K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Atossa Genetics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Atossa Genetics' short interest history, or implied volatility extrapolated from Atossa Genetics options trading.
Pair Trading with Atossa Genetics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atossa Genetics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atossa Genetics will appreciate offsetting losses from the drop in the long position's value.Moving together with Atossa Stock
| 0.77 | NXL | Nexalin Technology | PairCorr |
Moving against Atossa Stock
| 0.8 | SINT | SINTX Technologies | PairCorr |
| 0.78 | BBLG | Bone Biologics Corp Financial Report 20th of May 2024 | PairCorr |
| 0.77 | HCAT | Health Catalyst Financial Report 14th of May 2024 | PairCorr |
| 0.7 | UNH | UnitedHealth Group Financial Report 12th of July 2024 | PairCorr |
| 0.68 | PRVA | Privia Health Group Financial Report 2nd of May 2024 | PairCorr |
The ability to find closely correlated positions to Atossa Genetics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atossa Genetics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atossa Genetics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atossa Genetics to buy it.
The correlation of Atossa Genetics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atossa Genetics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atossa Genetics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atossa Genetics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Atossa Genetics Piotroski F Score and Atossa Genetics Altman Z Score analysis. For more information on how to buy Atossa Stock please use our How to Invest in Atossa Genetics guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Atossa Stock analysis
When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
Is Atossa Genetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atossa Genetics. If investors know Atossa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atossa Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.24) | Return On Assets (0.18) | Return On Equity (0.29) |
The market value of Atossa Genetics is measured differently than its book value, which is the value of Atossa that is recorded on the company's balance sheet. Investors also form their own opinion of Atossa Genetics' value that differs from its market value or its book value, called intrinsic value, which is Atossa Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atossa Genetics' market value can be influenced by many factors that don't directly affect Atossa Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atossa Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Atossa Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atossa Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.